首页 > 最新文献

Pituitary最新文献

英文 中文
Two-stage surgery for cystic craniopharyngiomas: a purely endoscopic strategy and outcomes. 两阶段手术治疗囊性颅咽管瘤:纯内窥镜策略和结果。
IF 3.4 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-12-21 DOI: 10.1007/s11102-025-01618-w
Yoshiki Sato, Kazuhito Takeuchi, Yuichi Nagata, Tomoki Matsuyama, Toshiaki Hirose, Eriko Okumura, Kenichiro Iwami, Ryuta Saito

Purpose: This study aimed to evaluate the effectiveness and safety of two-stage endoscopic surgery for the complete resection of cystic craniopharyngiomas.

Methods: We retrospectively evaluated 11 patients who underwent two-stage endoscopic surgery between March 2020 and July 2025. The lesions showed suprasellar and lateral extension toward the optic chiasm or the foramen of Monro, resulting in visual impairment or obstructive hydrocephalus. Cyst fenestration (CF) was initially performed using a transventricular approach with a flexible endoscope. One to two months later, endoscopic transsphenoidal surgery (eTSS) was performed to achieve complete resection. Tumor size (vertical diameter, horizontal diameter, and volume) was measured at three time points: pre-CF, post-CF (≤ 4 days), and pre-eTSS. Extent of resection, recurrence, and pituitary and hypothalamic function were assessed post-eTSS.

Results: Complete resection was achieved in 10 of 11 patients, with no recurrence during a median follow-up of 22.8 months (range, 3.6-65.3). At a median interval of 54 days (range, 27-86) between CF and eTSS, the mean linear reduction was 45.3% superiorly and 39.3% laterally; mean tumor volume decreased by 68.0%. In some cases, areas typically difficult to access via eTSS alone decreased in size. All preoperative symptoms, except for hypopituitarism and diabetes insipidus, improved immediately after CF. No hypothalamic dysfunction was observed.

Conclusion: Two-stage endoscopic surgery for cystic craniopharyngiomas is effective and safe, enabling complete resection with low recurrence during short- to mid-term follow-up.

目的:本研究旨在评价两期内镜手术完全切除囊性颅咽管瘤的有效性和安全性。方法:我们回顾性评估了11例在2020年3月至2025年7月期间接受了两期内窥镜手术的患者。病变表现为鞍上及外侧向视交叉或Monro孔延伸,导致视力障碍或梗阻性脑积水。囊肿开窗术(CF)最初采用柔性内窥镜经脑室入路进行。1 ~ 2个月后,行内镜下经蝶窦手术(eTSS)实现全切除。在cf前、cf后(≤4天)和etss前三个时间点测量肿瘤大小(垂直直径、水平直径和体积)。etss后评估切除程度、复发、垂体和下丘脑功能。结果:11例患者中有10例完全切除,中位随访22.8个月(范围3.6-65.3)无复发。在CF和eTSS之间的中位间隔54天(范围,27-86),平均线性下降为45.3%,横向下降为39.3%;平均肿瘤体积缩小68.0%。在某些情况下,通常仅通过eTSS难以进入的区域缩小了。除垂体功能低下和尿崩症外,CF后所有术前症状均立即改善。未观察到下丘脑功能障碍。结论:两期内镜手术治疗囊性颅咽管瘤是一种安全有效的手术方法,在中短期随访中能完全切除,复发率低。
{"title":"Two-stage surgery for cystic craniopharyngiomas: a purely endoscopic strategy and outcomes.","authors":"Yoshiki Sato, Kazuhito Takeuchi, Yuichi Nagata, Tomoki Matsuyama, Toshiaki Hirose, Eriko Okumura, Kenichiro Iwami, Ryuta Saito","doi":"10.1007/s11102-025-01618-w","DOIUrl":"https://doi.org/10.1007/s11102-025-01618-w","url":null,"abstract":"<p><strong>Purpose: </strong>This study aimed to evaluate the effectiveness and safety of two-stage endoscopic surgery for the complete resection of cystic craniopharyngiomas.</p><p><strong>Methods: </strong>We retrospectively evaluated 11 patients who underwent two-stage endoscopic surgery between March 2020 and July 2025. The lesions showed suprasellar and lateral extension toward the optic chiasm or the foramen of Monro, resulting in visual impairment or obstructive hydrocephalus. Cyst fenestration (CF) was initially performed using a transventricular approach with a flexible endoscope. One to two months later, endoscopic transsphenoidal surgery (eTSS) was performed to achieve complete resection. Tumor size (vertical diameter, horizontal diameter, and volume) was measured at three time points: pre-CF, post-CF (≤ 4 days), and pre-eTSS. Extent of resection, recurrence, and pituitary and hypothalamic function were assessed post-eTSS.</p><p><strong>Results: </strong>Complete resection was achieved in 10 of 11 patients, with no recurrence during a median follow-up of 22.8 months (range, 3.6-65.3). At a median interval of 54 days (range, 27-86) between CF and eTSS, the mean linear reduction was 45.3% superiorly and 39.3% laterally; mean tumor volume decreased by 68.0%. In some cases, areas typically difficult to access via eTSS alone decreased in size. All preoperative symptoms, except for hypopituitarism and diabetes insipidus, improved immediately after CF. No hypothalamic dysfunction was observed.</p><p><strong>Conclusion: </strong>Two-stage endoscopic surgery for cystic craniopharyngiomas is effective and safe, enabling complete resection with low recurrence during short- to mid-term follow-up.</p>","PeriodicalId":20202,"journal":{"name":"Pituitary","volume":"29 1","pages":"21"},"PeriodicalIF":3.4,"publicationDate":"2025-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145805314","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Author's reply to the Letter to the Editor by M Vijayasimha "Standardizing blood pressure phenotyping in acromegaly: a practical companion to Araujo-Castro et al." 作者对M Vijayasimha给编辑的信的回复“规范肢端肥大症的血压表型:Araujo-Castro等人的实用伴侣”。
IF 3.4 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-12-21 DOI: 10.1007/s11102-025-01623-z
Marta Araujo-Castro, Pedro Marques, Betina Biagetti
{"title":"Author's reply to the Letter to the Editor by M Vijayasimha \"Standardizing blood pressure phenotyping in acromegaly: a practical companion to Araujo-Castro et al.\"","authors":"Marta Araujo-Castro, Pedro Marques, Betina Biagetti","doi":"10.1007/s11102-025-01623-z","DOIUrl":"https://doi.org/10.1007/s11102-025-01623-z","url":null,"abstract":"","PeriodicalId":20202,"journal":{"name":"Pituitary","volume":"29 1","pages":"22"},"PeriodicalIF":3.4,"publicationDate":"2025-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145805295","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Controlling cortisol excess and comorbidities in Cushing's syndrome with osilodrostat. 奥西洛他汀控制库欣综合征皮质醇过量及合并症。
IF 3.4 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-12-21 DOI: 10.1007/s11102-025-01605-1
Maria Fleseriu, John Newell-Price, Mônica R Gadelha, Beverly M K Biller
{"title":"Controlling cortisol excess and comorbidities in Cushing's syndrome with osilodrostat.","authors":"Maria Fleseriu, John Newell-Price, Mônica R Gadelha, Beverly M K Biller","doi":"10.1007/s11102-025-01605-1","DOIUrl":"10.1007/s11102-025-01605-1","url":null,"abstract":"","PeriodicalId":20202,"journal":{"name":"Pituitary","volume":"29 1","pages":"20"},"PeriodicalIF":3.4,"publicationDate":"2025-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12719344/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145805235","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgical management in very elderly patients with pituitary adenoma: a multivariable assessment of the surveillance, epidemiology, and end results database. 高龄垂体腺瘤患者的手术治疗:监测、流行病学和最终结果数据库的多变量评估。
IF 3.4 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-12-20 DOI: 10.1007/s11102-025-01612-2
Jacob Gould, Arjit Singh, Saarang Patel, Noah Yaffe, Guan Li, Lou Blanpain, Julian L Gendreau

Background: The management of pituitary adenomas in very elderly patients (age ≥ 85 years) remains challenging due to age-related frailty and variability in treatment tolerance. This study aimed to identify clinical and sociodemographic factors associated with survival in patients age ≥ 85 years with pituitary adenoma and assess the plausibility of surgical resection.

Methods: Patients aged 85 and up (very elderly cohort) were queried from the SEER database. Additionally, patients from the age range of 75-84 (elderly cohort) were queried for comparisons. Demographic variables, adenoma size, and treatment variables were assessed, and differences were identified using a Chi-squared tests for independence and two-sample t-tests. Differences in survival were assessed using multivariable Cox proportional hazards models stratified by age cohort. Kaplan-Meier plots were generated to assess survival differences among treatment groups in the very elderly cohort.

Results: Across all cohorts, subtotal resection and female sex were independently associated with improved survival and age was associated with worse survival. For the very elderly cohort, adenoma size (HR = 1.004; p = 0.005) was associated with worse overall survival, while female sex (HR = 0.656; p < 0.001) and subtotal resection (HR = 0.557; p = 0.005) were associated with increased overall survival. Black race was associated with worse survival in the 75-84 elderly cohort only (HR = 1.479; p < 0.001).

Conclusion: In patients ≥ 85 years of age with pituitary adenoma, surgical resection appears to provide an overall benefit to survival and should be considered among other factors.

背景:高龄患者(≥85岁)的垂体腺瘤的治疗仍然具有挑战性,因为年龄相关的虚弱和治疗耐受性的变化。本研究旨在确定与年龄≥85岁垂体腺瘤患者生存相关的临床和社会人口学因素,并评估手术切除的可行性。方法:从SEER数据库中查询年龄在85岁及以上的患者(高龄队列)。此外,还查询了年龄在75-84岁(老年队列)的患者进行比较。对人口统计学变量、腺瘤大小和治疗变量进行评估,并使用卡方检验和两样本t检验确定差异。生存率差异采用多变量Cox比例风险模型按年龄队列分层进行评估。生成Kaplan-Meier图来评估老年队列中治疗组之间的生存差异。结果:在所有队列中,次全切除术和女性与生存率的提高独立相关,年龄与生存率的降低相关。在高龄队列中,腺瘤大小(HR = 1.004; p = 0.005)与较差的总生存率相关,而女性(HR = 0.656; p)与较差的总生存率相关。结论:对于年龄≥85岁的垂体腺瘤患者,手术切除似乎对总体生存率有好处,应在其他因素中加以考虑。
{"title":"Surgical management in very elderly patients with pituitary adenoma: a multivariable assessment of the surveillance, epidemiology, and end results database.","authors":"Jacob Gould, Arjit Singh, Saarang Patel, Noah Yaffe, Guan Li, Lou Blanpain, Julian L Gendreau","doi":"10.1007/s11102-025-01612-2","DOIUrl":"https://doi.org/10.1007/s11102-025-01612-2","url":null,"abstract":"<p><strong>Background: </strong>The management of pituitary adenomas in very elderly patients (age ≥ 85 years) remains challenging due to age-related frailty and variability in treatment tolerance. This study aimed to identify clinical and sociodemographic factors associated with survival in patients age ≥ 85 years with pituitary adenoma and assess the plausibility of surgical resection.</p><p><strong>Methods: </strong>Patients aged 85 and up (very elderly cohort) were queried from the SEER database. Additionally, patients from the age range of 75-84 (elderly cohort) were queried for comparisons. Demographic variables, adenoma size, and treatment variables were assessed, and differences were identified using a Chi-squared tests for independence and two-sample t-tests. Differences in survival were assessed using multivariable Cox proportional hazards models stratified by age cohort. Kaplan-Meier plots were generated to assess survival differences among treatment groups in the very elderly cohort.</p><p><strong>Results: </strong>Across all cohorts, subtotal resection and female sex were independently associated with improved survival and age was associated with worse survival. For the very elderly cohort, adenoma size (HR = 1.004; p = 0.005) was associated with worse overall survival, while female sex (HR = 0.656; p < 0.001) and subtotal resection (HR = 0.557; p = 0.005) were associated with increased overall survival. Black race was associated with worse survival in the 75-84 elderly cohort only (HR = 1.479; p < 0.001).</p><p><strong>Conclusion: </strong>In patients ≥ 85 years of age with pituitary adenoma, surgical resection appears to provide an overall benefit to survival and should be considered among other factors.</p>","PeriodicalId":20202,"journal":{"name":"Pituitary","volume":"29 1","pages":"18"},"PeriodicalIF":3.4,"publicationDate":"2025-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145800313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic performance of desmopressin stimulation test in pediatric cushing's disease. 去氨加压素刺激试验对儿童库欣病的诊断价值。
IF 3.4 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-12-20 DOI: 10.1007/s11102-025-01610-4
Yetunde B Omotosho, Richard Chang, Michael Kassin, Erna Groat, Alan Quillian, Ruth Parker, Christina Tatsi
{"title":"Diagnostic performance of desmopressin stimulation test in pediatric cushing's disease.","authors":"Yetunde B Omotosho, Richard Chang, Michael Kassin, Erna Groat, Alan Quillian, Ruth Parker, Christina Tatsi","doi":"10.1007/s11102-025-01610-4","DOIUrl":"10.1007/s11102-025-01610-4","url":null,"abstract":"","PeriodicalId":20202,"journal":{"name":"Pituitary","volume":"29 1","pages":"19"},"PeriodicalIF":3.4,"publicationDate":"2025-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12718224/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145800255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The efficacy of minimally invasive intraoperative ultrasound in endoscopic pituitary surgery. 微创术中超声在垂体内镜手术中的应用效果。
IF 3.4 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-12-16 DOI: 10.1007/s11102-025-01587-0
Min Ho Lee, Yeon Hee Im, Ji-Hyeon Shin, Tae-Kyu Lee

Objective: This study aims to evaluate the clinical utility of minimally invasive intraoperative ultrasound as a real-time imaging adjunct during endoscopic endonasal pituitary adenoma surgery. The goal is to determine its effectiveness in tumor localization, identification of critical structures, and detection of residual tumor tissue.

Methods: A retrospective analysis was conducted on 22 patients who underwent endoscopic endonasal pituitary surgery with intraoperative ultrasound at our institution from August 2024 to June 2025. The ultrasound probe was used before dural opening to identify the tumor, normal gland, and adjacent structures, including the internal carotid artery (ICA). After tumor resection, ultrasound was employed to assess residual tumor. Clinical and surgical outcomes, including extent of resection and perioperative complications, were reviewed.

Results: Intraoperative ultrasound enabled clear visualization of the tumor-normal gland interface in both solid and cystic macroadenomas, facilitating safe and precise resection. The technique aided in identification of the ICA during cavernous sinus invasion, reducing vascular injury risk. In cases where tumors were not visible on preoperative magnetic resonance imaging (MRI), intraoperative ultrasound successfully detected the lesions, allowing targeted resection. Gross total resection (GTR) was achieved in 86.4% of cases. The median follow-up was 8 months (range, 3-13 months). There were no new postoperative hormonal deficits. Transient diabetes insipidus occurred in three cases, and all resolved within three months.

Conclusion: Intraoperative ultrasound provides real-time, high-resolution imaging that enhances the precision and safety of endoscopic pituitary surgery. The technique is particularly valuable for tumor localization, identification of critical neurovascular structures, and detection of residual tumor tissue. Further studies are warranted to validate a broader applicability and refine its role in differentiating tumor from normal gland tissue.

目的:本研究旨在评估微创术中超声作为鼻内垂体腺瘤内镜手术中实时成像辅助手段的临床应用价值。目的是确定其在肿瘤定位、关键结构识别和残留肿瘤组织检测中的有效性。方法:回顾性分析我院2024年8月至2025年6月22例经鼻内窥镜下垂体手术伴术中超声的患者。在硬脑膜打开前使用超声探头识别肿瘤、正常腺体和邻近结构,包括颈内动脉(ICA)。肿瘤切除后,超声检查残余肿瘤。回顾了临床和手术结果,包括切除程度和围手术期并发症。结果:术中超声能清晰显示实性和囊性大腺瘤的瘤-正常腺体界面,便于安全、精确的切除。该技术有助于识别海绵窦侵袭时的ICA,降低血管损伤的风险。在术前磁共振成像(MRI)未见肿瘤的病例中,术中超声成功地检测到病变,允许靶向切除。总切除(GTR)率达86.4%。中位随访为8个月(范围3-13个月)。术后无新的激素缺乏。短暂性尿崩症3例,均在3个月内痊愈。结论:术中超声可提供实时、高分辨率成像,提高垂体内镜手术的精度和安全性。该技术对肿瘤定位、关键神经血管结构的识别和残留肿瘤组织的检测尤其有价值。需要进一步的研究来验证其更广泛的适用性,并完善其在区分肿瘤与正常腺体组织中的作用。
{"title":"The efficacy of minimally invasive intraoperative ultrasound in endoscopic pituitary surgery.","authors":"Min Ho Lee, Yeon Hee Im, Ji-Hyeon Shin, Tae-Kyu Lee","doi":"10.1007/s11102-025-01587-0","DOIUrl":"https://doi.org/10.1007/s11102-025-01587-0","url":null,"abstract":"<p><strong>Objective: </strong>This study aims to evaluate the clinical utility of minimally invasive intraoperative ultrasound as a real-time imaging adjunct during endoscopic endonasal pituitary adenoma surgery. The goal is to determine its effectiveness in tumor localization, identification of critical structures, and detection of residual tumor tissue.</p><p><strong>Methods: </strong>A retrospective analysis was conducted on 22 patients who underwent endoscopic endonasal pituitary surgery with intraoperative ultrasound at our institution from August 2024 to June 2025. The ultrasound probe was used before dural opening to identify the tumor, normal gland, and adjacent structures, including the internal carotid artery (ICA). After tumor resection, ultrasound was employed to assess residual tumor. Clinical and surgical outcomes, including extent of resection and perioperative complications, were reviewed.</p><p><strong>Results: </strong>Intraoperative ultrasound enabled clear visualization of the tumor-normal gland interface in both solid and cystic macroadenomas, facilitating safe and precise resection. The technique aided in identification of the ICA during cavernous sinus invasion, reducing vascular injury risk. In cases where tumors were not visible on preoperative magnetic resonance imaging (MRI), intraoperative ultrasound successfully detected the lesions, allowing targeted resection. Gross total resection (GTR) was achieved in 86.4% of cases. The median follow-up was 8 months (range, 3-13 months). There were no new postoperative hormonal deficits. Transient diabetes insipidus occurred in three cases, and all resolved within three months.</p><p><strong>Conclusion: </strong>Intraoperative ultrasound provides real-time, high-resolution imaging that enhances the precision and safety of endoscopic pituitary surgery. The technique is particularly valuable for tumor localization, identification of critical neurovascular structures, and detection of residual tumor tissue. Further studies are warranted to validate a broader applicability and refine its role in differentiating tumor from normal gland tissue.</p>","PeriodicalId":20202,"journal":{"name":"Pituitary","volume":"29 1","pages":"17"},"PeriodicalIF":3.4,"publicationDate":"2025-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145763516","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Standardizing blood pressure phenotyping in acromegaly: A practical companion to Araujo-Castro et al. 规范肢端肥大症的血压表型:Araujo-Castro等人的实用伴侣。
IF 3.4 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-12-10 DOI: 10.1007/s11102-025-01620-2
M Vijayasimha

Hypertension affects nearly half of patients with acromegaly, yet current studies inconsistently report blood pressure phenotypes due to variability in the use of office, home, and ambulatory monitoring. This companion article proposes a standardized, risk-stratified approach using ambulatory and home blood pressure monitoring to classify sustained, masked, and nocturnal hypertension and to guide antihypertensive de-escalation in relation to biochemical control. The framework incorporates key timepoints-diagnosis, early post-therapy reassessment, and long-term follow-up-while emphasizing modality-specific diagnostic thresholds, dipping patterns, and cardiovascular risk profiles. Structured follow-up using periodic ambulatory blood pressure monitoring and validated home monitoring enables more precise phenotyping, optimizes treatment decisions, and improves comparability across future acromegaly cohorts.

高血压影响近一半的肢端肥大症患者,但由于办公室、家庭和门诊监测的使用差异,目前的研究不一致地报告了血压表型。这篇文章提出了一种标准化的、风险分层的方法,使用动态和家庭血压监测对持续、隐匿和夜间高血压进行分类,并指导与生化控制相关的降压。该框架纳入了关键时间点——诊断、早期治疗后再评估和长期随访,同时强调了特定模式的诊断阈值、倾斜模式和心血管风险概况。采用定期动态血压监测和经过验证的家庭监测进行结构化随访,可以更精确地进行表型分析,优化治疗决策,并提高未来肢端肥大症队列的可比性。
{"title":"Standardizing blood pressure phenotyping in acromegaly: A practical companion to Araujo-Castro et al.","authors":"M Vijayasimha","doi":"10.1007/s11102-025-01620-2","DOIUrl":"10.1007/s11102-025-01620-2","url":null,"abstract":"<p><p>Hypertension affects nearly half of patients with acromegaly, yet current studies inconsistently report blood pressure phenotypes due to variability in the use of office, home, and ambulatory monitoring. This companion article proposes a standardized, risk-stratified approach using ambulatory and home blood pressure monitoring to classify sustained, masked, and nocturnal hypertension and to guide antihypertensive de-escalation in relation to biochemical control. The framework incorporates key timepoints-diagnosis, early post-therapy reassessment, and long-term follow-up-while emphasizing modality-specific diagnostic thresholds, dipping patterns, and cardiovascular risk profiles. Structured follow-up using periodic ambulatory blood pressure monitoring and validated home monitoring enables more precise phenotyping, optimizes treatment decisions, and improves comparability across future acromegaly cohorts.</p>","PeriodicalId":20202,"journal":{"name":"Pituitary","volume":"29 1","pages":"16"},"PeriodicalIF":3.4,"publicationDate":"2025-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145715458","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
From misclassified AIP variant to carney complex: a case report and retrospective evaluation of PRKAR1A in pituitary tumor predisposition. 从错误分类的AIP变异到卡尼复合物:PRKAR1A在垂体肿瘤易感性中的一个病例报告和回顾性评估。
IF 3.4 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-12-09 DOI: 10.1007/s11102-025-01616-y
Cécilia Piazzola, Lauriane Le Collen, Théo Charnay, Bénédicte Decoudier, Frédérique Albarel, Nicolas Macagno, Frédéric Castinetti, Anne Barlier, Brigitte Delemer, Pauline Romanet, Auragen Consortium

Context: Carney Complex (CNC) is a rare multiple endocrine neoplasia syndrome, due to PRKAR1A mutation, that causes GH-secreting pituitary adenomas (PA) in 10% of patients. PRKAR1A is not currently analyzed in patients with isolated sporadic or familial PA, in contrast to MEN1 or AIP.

Objective: We report the case of a young man diagnosed with a PA at age 21 during melanoma follow-up, with a family history of PA. He was initially misdiagnosed with FIPA due to a misclassified AIP mutation, before a final diagnosis of CNC was established. We subsequently retrospectively analysed PRKAR1A in a cohort of patients with PA to assess the relevance of includingPRKAR1A in PA predisposition gene panels.

Methods: After AIP variant reclassification and whole genome analysis of the patient, we performed a retrospective analysis of the genetic and clinical data of patients who underwent germline genetic testing for hereditary predisposition to PA.

Results: Two hundred and twenty patients were included, of whom 16 (7.3%) had a family history of PA, 162 (72.7%) had macro-PA, and 54 (24.6%) had GH- or GH/PRL-secreting PA. Four patients (1.8%) carried pathogenic variants in AIP or MEN1, but none in PRKAR1A.

Conclusion: This case underscores the importance of periodically reassessing genetic variants, as reclassification can significantly impact patient management. It also highlights the clinical variability of CNC and the need to screen for CNC features in young patients with acromegaly. Further research is warranted to determine the value ofPRKAR1A testing in isolated GH- and GH/PRL-secreting PA.

背景:Carney Complex (CNC)是一种罕见的多发性内分泌瘤变综合征,由PRKAR1A突变引起,10%的患者可导致gh分泌垂体腺瘤(PA)。与MEN1或AIP相比,PRKAR1A目前尚未在孤立散发或家族性PA患者中进行分析。目的:我们报告一个年轻的男子在21岁时被诊断为黑色素瘤随访期间,有家族病史的PA。在最终诊断为CNC之前,由于错误分类的AIP突变,他最初被误诊为FIPA。随后,我们回顾性分析了一组PA患者的PRKAR1A,以评估将PRKAR1A纳入PA易感基因面板的相关性。方法:在对患者进行AIP变异重分类和全基因组分析后,我们对接受种系基因检测的PA遗传易感性患者的遗传和临床资料进行了回顾性分析。结果:共纳入220例患者,其中PA家族史16例(7.3%),巨量PA 162例(72.7%),GH或GH/ prl分泌型PA 54例(24.6%)。4例患者(1.8%)携带AIP或MEN1致病变异,但没有PRKAR1A致病变异。结论:该病例强调了定期重新评估遗传变异的重要性,因为重新分类可以显著影响患者的管理。它还强调了CNC的临床变异性以及筛查年轻肢端肥大患者CNC特征的必要性。需要进一步的研究来确定prkar1a检测在分离的GH-和GH/ prl分泌的PA中的价值。
{"title":"From misclassified AIP variant to carney complex: a case report and retrospective evaluation of PRKAR1A in pituitary tumor predisposition.","authors":"Cécilia Piazzola, Lauriane Le Collen, Théo Charnay, Bénédicte Decoudier, Frédérique Albarel, Nicolas Macagno, Frédéric Castinetti, Anne Barlier, Brigitte Delemer, Pauline Romanet, Auragen Consortium","doi":"10.1007/s11102-025-01616-y","DOIUrl":"10.1007/s11102-025-01616-y","url":null,"abstract":"<p><strong>Context: </strong>Carney Complex (CNC) is a rare multiple endocrine neoplasia syndrome, due to PRKAR1A mutation, that causes GH-secreting pituitary adenomas (PA) in 10% of patients. PRKAR1A is not currently analyzed in patients with isolated sporadic or familial PA, in contrast to MEN1 or AIP.</p><p><strong>Objective: </strong>We report the case of a young man diagnosed with a PA at age 21 during melanoma follow-up, with a family history of PA. He was initially misdiagnosed with FIPA due to a misclassified AIP mutation, before a final diagnosis of CNC was established. We subsequently retrospectively analysed PRKAR1A in a cohort of patients with PA to assess the relevance of includingPRKAR1A in PA predisposition gene panels.</p><p><strong>Methods: </strong>After AIP variant reclassification and whole genome analysis of the patient, we performed a retrospective analysis of the genetic and clinical data of patients who underwent germline genetic testing for hereditary predisposition to PA.</p><p><strong>Results: </strong>Two hundred and twenty patients were included, of whom 16 (7.3%) had a family history of PA, 162 (72.7%) had macro-PA, and 54 (24.6%) had GH- or GH/PRL-secreting PA. Four patients (1.8%) carried pathogenic variants in AIP or MEN1, but none in PRKAR1A.</p><p><strong>Conclusion: </strong>This case underscores the importance of periodically reassessing genetic variants, as reclassification can significantly impact patient management. It also highlights the clinical variability of CNC and the need to screen for CNC features in young patients with acromegaly. Further research is warranted to determine the value ofPRKAR1A testing in isolated GH- and GH/PRL-secreting PA.</p>","PeriodicalId":20202,"journal":{"name":"Pituitary","volume":"29 1","pages":"15"},"PeriodicalIF":3.4,"publicationDate":"2025-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145708844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between vertebral fracture risk and bone mineral density in patients with acromegaly. 肢端肥大症患者椎体骨折风险与骨密度的关系。
IF 3.4 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-12-09 DOI: 10.1007/s11102-025-01615-z
Shuaiming Chen, Min Liu, Huiwen Tan, Lin Ji, Yerong Yu, Shu Jiang, Bowen Cai, Wei Wang, Songping Zheng, Xin Zan, Huan Xu, Jing Li, Jianwei Li

Purpose: To investigate the prevalence and risk factors of vertebral fractures (VFs) and to compare bone mineral density (BMD) assessments by dual-energy X-ray absorptiometry (DXA) and quantitative computed tomography (QCT) in patients with acromegaly.

Methods: This cross-sectional study included 149 patients with acromegaly. Clinical, biochemical, and imaging data were collected, and logistic regression analyses were performed to identify VF risk factors.

Results: VFs were detected in 39.6% of patients and were associated with older age, longer disease duration, higher body mass index(BMI), elevated IGF-1 levels, and lower serum phosphorus. QCT-derived volumetric BMD (vBMD) was significantly lower in patients with VFs, whereas DXA-based lumbar areal BMD (aBMD) did not differ between groups. Elevated IGF-1 (%ULN) and reduced vBMD were identified as independent risk factors for VFs.

Conclusion: Vertebral fractures are common in acromegaly. In one of the largest Chinese acromegaly cohorts to date, QCT demonstrated superior discrimination of VF risk compared with DXA, supporting its potential complementary role in skeletal fragility assessment in acromegaly.

目的:探讨肢端肥大症患者椎体骨折(VFs)的患病率和危险因素,并比较双能x线骨密度(DXA)和定量计算机断层扫描(QCT)对骨密度(BMD)的评估。方法:对149例肢端肥大症患者进行横断面研究。收集临床、生化和影像学资料,并进行logistic回归分析,以确定VF的危险因素。结果:39.6%的患者检测到VFs,并与年龄较大、病程较长、体重指数(BMI)较高、IGF-1水平升高和血清磷降低相关。qct衍生的体积骨密度(vBMD)在VFs患者中显著降低,而基于dx的腰椎面积骨密度(aBMD)在两组之间没有差异。升高的IGF-1 (%ULN)和降低的vBMD被确定为室性心肌病的独立危险因素。结论:肢端肥大症常见椎体骨折。在迄今为止最大的中国肢端肥大症队列之一中,与DXA相比,QCT显示出更强的VF风险辨别能力,支持其在肢端肥大症骨骼脆弱性评估中的潜在补充作用。
{"title":"Association between vertebral fracture risk and bone mineral density in patients with acromegaly.","authors":"Shuaiming Chen, Min Liu, Huiwen Tan, Lin Ji, Yerong Yu, Shu Jiang, Bowen Cai, Wei Wang, Songping Zheng, Xin Zan, Huan Xu, Jing Li, Jianwei Li","doi":"10.1007/s11102-025-01615-z","DOIUrl":"10.1007/s11102-025-01615-z","url":null,"abstract":"<p><strong>Purpose: </strong>To investigate the prevalence and risk factors of vertebral fractures (VFs) and to compare bone mineral density (BMD) assessments by dual-energy X-ray absorptiometry (DXA) and quantitative computed tomography (QCT) in patients with acromegaly.</p><p><strong>Methods: </strong>This cross-sectional study included 149 patients with acromegaly. Clinical, biochemical, and imaging data were collected, and logistic regression analyses were performed to identify VF risk factors.</p><p><strong>Results: </strong>VFs were detected in 39.6% of patients and were associated with older age, longer disease duration, higher body mass index(BMI), elevated IGF-1 levels, and lower serum phosphorus. QCT-derived volumetric BMD (vBMD) was significantly lower in patients with VFs, whereas DXA-based lumbar areal BMD (aBMD) did not differ between groups. Elevated IGF-1 (%ULN) and reduced vBMD were identified as independent risk factors for VFs.</p><p><strong>Conclusion: </strong>Vertebral fractures are common in acromegaly. In one of the largest Chinese acromegaly cohorts to date, QCT demonstrated superior discrimination of VF risk compared with DXA, supporting its potential complementary role in skeletal fragility assessment in acromegaly.</p>","PeriodicalId":20202,"journal":{"name":"Pituitary","volume":"29 1","pages":"12"},"PeriodicalIF":3.4,"publicationDate":"2025-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145708835","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An endocrinological point of view on a large series of pituitary stalk lesions. 垂体柄大范围病变的内分泌学观点。
IF 3.4 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-12-09 DOI: 10.1007/s11102-025-01617-x
Alperen Onur İşler, Suleyman Nahit Sendur, Rahsan Gocmen, Figen Soylemezoglu, Selcuk Dagdelen, Tomris Erbas

Purpose: Pituitary stalk lesions (PSL) present unresolved etiological and diagnostic challenges. This study provides a comprehensive clinical analysis to address these gaps.

Methods: We retrospectively evaluated 98 adults with pituitary stalk (PS) abnormalities, assessing PS features, demographics, clinical data, hormonal profiles, imaging, pathology, diagnoses, and treatments.

Results: Among 98 patients (59 F/39 M; median age 37 years), PS thickening was most frequent (52%), followed by thinning (18.4%) and nodularity (17.3%). The distribution of lesion types varied significantly across etiological categories (p < 0.001). Thickening was most frequent in inflammatory etiologies, thinning in unclassifiable cases, and nodularity in inflammatory etiologies. Solid organ metastases occurred in older patients. Arginine vasopressin deficiency (AVP-D) rates ranged from 57% to 61% in non-adenomatous local neoplastic lesions, inflammatory etiologies, and solid organ metastases. Congenital cases mainly had growth retardation and gonadal dysfunction. Extrapituitary involvement was highest in solid organ metastases, followed by inflammatory etiologies, and non-adenoma local neoplastic lesions. PS thickening was more pronounced in solid organ metastases. Isolated PS involvement was most often (25%) due to Langerhans cell histiocytosis. In PSIS, all had ectopic neurohypophysis, lacked AVP-D, and showed at least one anterior pituitary hormone deficiency.

Conclusion: In conclusion, we describe a unique series of PSL that contribute to the understanding of the heterogeneous spectrum of PSL. In this study, we discuss the clinical and radiological features of PSL and provide current recommendations for differential diagnosis.

目的:垂体柄病变(PSL)目前尚未解决的病因和诊断挑战。本研究提供了一个全面的临床分析,以解决这些差距。方法:我们回顾性评估了98例垂体柄(PS)异常的成年人,评估了PS的特征、人口统计学、临床资料、激素谱、影像学、病理、诊断和治疗。结果:98例患者(59 F/39 M,中位年龄37岁)中,PS增厚最常见(52%),其次是变薄(18.4%)和结节(17.3%)。不同病因类型的病变类型分布差异显著(p结论:总之,我们描述了一系列独特的PSL,有助于理解PSL的异质性谱。在本研究中,我们讨论PSL的临床和影像学特征,并提供当前的鉴别诊断建议。
{"title":"An endocrinological point of view on a large series of pituitary stalk lesions.","authors":"Alperen Onur İşler, Suleyman Nahit Sendur, Rahsan Gocmen, Figen Soylemezoglu, Selcuk Dagdelen, Tomris Erbas","doi":"10.1007/s11102-025-01617-x","DOIUrl":"https://doi.org/10.1007/s11102-025-01617-x","url":null,"abstract":"<p><strong>Purpose: </strong>Pituitary stalk lesions (PSL) present unresolved etiological and diagnostic challenges. This study provides a comprehensive clinical analysis to address these gaps.</p><p><strong>Methods: </strong>We retrospectively evaluated 98 adults with pituitary stalk (PS) abnormalities, assessing PS features, demographics, clinical data, hormonal profiles, imaging, pathology, diagnoses, and treatments.</p><p><strong>Results: </strong>Among 98 patients (59 F/39 M; median age 37 years), PS thickening was most frequent (52%), followed by thinning (18.4%) and nodularity (17.3%). The distribution of lesion types varied significantly across etiological categories (p < 0.001). Thickening was most frequent in inflammatory etiologies, thinning in unclassifiable cases, and nodularity in inflammatory etiologies. Solid organ metastases occurred in older patients. Arginine vasopressin deficiency (AVP-D) rates ranged from 57% to 61% in non-adenomatous local neoplastic lesions, inflammatory etiologies, and solid organ metastases. Congenital cases mainly had growth retardation and gonadal dysfunction. Extrapituitary involvement was highest in solid organ metastases, followed by inflammatory etiologies, and non-adenoma local neoplastic lesions. PS thickening was more pronounced in solid organ metastases. Isolated PS involvement was most often (25%) due to Langerhans cell histiocytosis. In PSIS, all had ectopic neurohypophysis, lacked AVP-D, and showed at least one anterior pituitary hormone deficiency.</p><p><strong>Conclusion: </strong>In conclusion, we describe a unique series of PSL that contribute to the understanding of the heterogeneous spectrum of PSL. In this study, we discuss the clinical and radiological features of PSL and provide current recommendations for differential diagnosis.</p>","PeriodicalId":20202,"journal":{"name":"Pituitary","volume":"29 1","pages":"11"},"PeriodicalIF":3.4,"publicationDate":"2025-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145708849","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Pituitary
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1